Financials Sectra AB

Equities

SECT B

SE0020539310

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm 09:30:00 20/06/2024 pm IST 5-day change 1st Jan Change
246.8 SEK +1.82% Intraday chart for Sectra AB -0.80% +36.91%

Valuation

Fiscal Period: April 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 12,350 16,173 23,308 24,169 31,157 47,550 - -
Enterprise Value (EV) 1 12,024 15,889 22,903 23,385 30,332 42,233 46,458 46,146
P/E ratio 62.3 x 68.2 x 84.6 x 76.6 x 82.9 x 98.7 x 90.4 x 75 x
Yield 1.4% 1.07% 0.74% 0.8% 0.68% 0.51% 0.53% 0.66%
Capitalization / Revenue 8.74 x 9.74 x 14.3 x 12.4 x 13.3 x 14.3 x 13.7 x 11.7 x
EV / Revenue 8.51 x 9.57 x 14 x 12 x 12.9 x 14.3 x 13.3 x 11.3 x
EV / EBITDA 42.6 x 42.5 x 52.9 x 50.3 x 55.4 x 67.9 x 60.1 x 49.8 x
EV / FCF 5,52,40,990 x 7,27,07,365 x 7,52,05,981 x 4,31,01,566 x 9,44,70,733 x - - -
FCF Yield 0% 0% 0% 0% 0% - - -
Price to Book 17 x 19.8 x 26 x 22.2 x 24 x 31.9 x 25.2 x 21 x
Nbr of stocks (in thousands) 1,91,764 1,92,530 1,92,627 1,93,662 1,92,685 1,92,667 - -
Reference price 2 64.40 84.00 121.0 124.8 161.7 246.8 246.8 246.8
Announcement Date 28/05/19 03/06/20 02/06/21 03/06/22 02/06/23 05/06/24 - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: April 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,414 1,661 1,632 1,949 2,351 2,964 3,481 4,071
EBITDA 1 282.4 373.6 433.2 464.6 547.6 621.9 772.8 926.9
EBIT 1 235.5 295.3 350.1 383.4 455.7 517.8 660.6 803.5
Operating Margin 16.66% 17.78% 21.45% 19.67% 19.38% 17.47% 18.98% 19.74%
Earnings before Tax (EBT) 1 248.8 303 348.2 394.5 479.4 552.8 676.7 814.4
Net income 1 199 237.4 275.5 314.8 375 428.4 525.8 632.8
Net margin 14.08% 14.29% 16.88% 16.15% 15.95% 14.45% 15.11% 15.54%
EPS 2 1.034 1.232 1.430 1.630 1.950 2.220 2.730 3.290
Free Cash Flow 217.7 218.5 304.5 542.5 321.1 - - -
FCF margin 15.4% 13.16% 18.66% 27.84% 13.66% - - -
FCF Conversion (EBITDA) 77.09% 58.49% 70.3% 116.78% 58.63% - - -
FCF Conversion (Net income) 109.39% 92.07% 110.53% 172.35% 85.63% - - -
Dividend per Share 2 0.9000 0.9000 0.9000 1.000 1.100 1.250 1.300 1.640
Announcement Date 28/05/19 03/06/20 02/06/21 03/06/22 02/06/23 05/06/24 - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: April 2022 Q2 2022 Q3 2022 Q4
Net sales 1 418.2 476.2 649
EBITDA 1 102.7 89.74 162.9
EBIT 1 83.71 68.44 141.1
Operating Margin 20.02% 14.37% 21.75%
Earnings before Tax (EBT) 1 83.95 77.04 141.4
Net income 1 66.34 62.88 112.5
Net margin 15.86% 13.21% 17.33%
EPS 0.3400 0.3300 -
Dividend per Share - - -
Announcement Date 10/12/21 09/03/22 03/06/22
1SEK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: April 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 325 284 405 784 825 891 1,092 1,404
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 218 219 305 543 321 - - -
ROE (net income / shareholders' equity) 29.8% 30.7% 32.2% 31.9% 31.5% 29.1% 30.5% 30.5%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 3.800 4.240 4.650 5.610 6.730 7.740 9.790 11.80
Cash Flow per Share - - - - - - - -
Capex 1 33 33 67.7 74.4 92.8 200 45 49.5
Capex / Sales 2.34% 1.98% 4.14% 3.82% 3.95% 7.12% 1.29% 1.22%
Announcement Date 28/05/19 03/06/20 02/06/21 03/06/22 02/06/23 05/06/24 - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
246.8 SEK
Average target price
167.5 SEK
Spread / Average Target
-32.13%
Consensus

Annual profits - Rate of surprise